H2S-Releasing Anti-Inflammatory Drugs for Arthritis and Inflammatory Bowel Disease - Paris Redox World Congress 2021 - October 14- 15, 2021

H2S-Releasing Anti-Inflammatory Drugs for Arthritis and Inflammatory Bowel Disease

Paris-Redox-2021-Speaker John-L-WallaceDr. John L. Wallace from University of Toronto, Canada will be joining the Paris Redox 2021 Congress and give speech about his recent study & result on H2S-Releasing Anti-Inflammatory Drugs for Arthritis and Inflammatory Bowel Disease.

Dr. Wallace is also founder of the Inflammation Research Network at the University of Calgary and inaugural director of the Farncombe Institute at McMaster University.

In November 2013, he became the tenth recipient of the Heymans Foundation Memorial Medal. Since its inauguration in 1972, the Medal had been awarded ten times; six of the previous recipients were Nobel Laureates.

The topic will discuss The development of H2S-releasing anti-inflammatory and analgesic drugs, with emphasis on the work humans have done. This will include clinical trial data and some underlying basic science on (surprising) aspects of the mechanism of action.

 

Paris Redox 2021 Congress
October 13-15, 2021 - Paris, France & Online
www.isanh.net

Redox in the Press & Media

  • 1
  • 2
  • 3
Prev Next